Science Center

Science Center is an accelerator based in Philadelphia, Pennsylvania, established in 1963. It fosters entrepreneurial activity and healthcare innovation by facilitating the commercialization of technology and promoting regional economic development. The organization brings together scientists, entrepreneurs, funding sources, laboratory facilities, and business services to enhance the availability of life-changing scientific breakthroughs. With a focus on the pharmaceuticals and biotechnology sectors, Science Center plays a vital role in supporting the growth of life sciences and technology companies, ultimately contributing to the advancement of healthcare and economic growth in the region.

Heath Naquin

Vice President Government and Capital Engagement

14 past transactions

Taurus Vascular

Non Equity Assistance in 2023
Taurus Vascular is a medical device company dedicated to enhancing long-term outcomes for patients with aortic aneurysms. The company is focused on developing innovative technology aimed at transforming the standard of care for these patients. Its novel medical device is designed to eliminate the adverse effects of endoleaks and promote accelerated shrinkage of aneurysm sacs following endovascular aortic aneurysm repair (EVAR). By addressing these critical issues, Taurus Vascular aims to improve patient outcomes within the healthcare industry.

AB Fertitlity

Pre Seed Round in 2023
AB Fertitlity develops products for reproductive medicine.

EmpiricaLab

Pre Seed Round in 2023
EmpiricaLab is an online learning platform tailored for healthcare teams, emphasizing last-mile training and collaborative authoring. The platform facilitates peer learning by allowing users to discover, create, and curate work-relevant content that enhances onboarding and productivity. By integrating learning directly into the work environment, EmpiricaLab supports knowledge transfer and collaboration among team members. This approach helps clients accelerate their digital transformation efforts by fostering a culture of continuous improvement and skill development within healthcare organizations.

MTDS Solution

Pre Seed Round in 2023
MTDS Solution is a health technology company that specializes in reducing the workload of medical institutions and enhancing community health. It develops fully automated kiosks for polymerase chain reaction (PCR) testing, allowing patients to purchase and conduct a variety of tests, including flu, sexually transmitted infections, blood-borne pathogens, genetic testing, and drug testing, using a mobile application.

Steradian Technologies

Seed Round in 2023
Steradian Technologies is a biotech company focused on developing noninvasive and fully portable diagnostic solutions for infectious diseases. The company specializes in a rapid COVID-19 detection test that utilizes advanced photon-based technology to identify pathogens within 30 seconds. By employing focal point projection systems that replicate human eyesight, Steradian’s approach eliminates the need for traditional laboratory settings, multiple testing steps, and extensive sample preparation. This innovative method not only enhances the speed of diagnosis but also maintains high accuracy in detecting a range of bacteria, viruses, and biomarkers. By streamlining the diagnostic process, Steradian Technologies aims to revolutionize patient care and provide clinicians with rapid and precise diagnostic capabilities.

Prana Thoracic

Non Equity Assistance in 2023
Prana Thoracic, Inc. is a Houston-based medical device startup focused on addressing the challenges of early intervention in lung cancer, which remains a leading cause of cancer-related deaths in the United States. The company aims to enhance screening and diagnosis by developing advanced surgical tools that facilitate the capture and analysis of small, suspicious lung nodules. Their innovative device employs a tissue-sparing electrosurgical technique that utilizes bipolar radiofrequency energy, allowing for simultaneous cutting and sealing. This approach minimizes the risk of complications associated with traditional methods, thereby improving the prospects for early detection and treatment. By providing physicians with more effective tools, Prana Thoracic seeks to revolutionize the management of lung cancer, ensuring that patients receive timely interventions and improving overall survival rates.

BioCurie

Pre Seed Round in 2023
BioCurie is developing an artificial intelligence software platform to better cell and gene therapy.

Trace Orthopedics

Seed Round in 2023
Trace Orthopedics specializes in innovative medical devices aimed at tendon reattachment without the need for surgery. The company has developed a minimally invasive procedure that utilizes a needle to insert a screw and wire coil implant, allowing for the repair of partially torn tendons directly to bone. This technique is designed to be performed without general anesthesia or the need for an operating room, facilitating a quicker recovery for patients and reducing overall healthcare costs. Through these advancements, Trace Orthopedics is transforming the approach to tendon injuries, making treatment more accessible and efficient.

Rubitection

Seed Round in 2023
Rubitection Inc. is a company based in Pittsburgh, Pennsylvania, specializing in early assessment and management of skin health, particularly focusing on the prevention of bedsores and diabetic foot ulcers. Founded in 2010, Rubitection has developed the Rubitect Assessment System, a handheld device designed for caregivers, doctors, and nurses to detect early signs of skin issues. This system provides features such as risk analytics, remote monitoring, and care plan management, allowing users to measure changes in tissue properties and assess overall skin health. Rubitection aims to establish itself as the global standard for skin health monitoring and care management, applicable not only in wound care but also in dermatology and cosmetic fields.

Aware.ai

Pre Seed Round in 2023
Aware.ai uses AI to create virtual support communities for women and connect them to resources during pregnancy.

Opal HTM

Seed Round in 2022
Opal HTM is a company focused on enhancing hospital safety and efficiency through innovative medical equipment management solutions. It has developed a healthcare equipment inventory management platform that aims to maximize the return on investment in technology. By optimizing procurement and maintenance strategies, Opal HTM helps healthcare managers improve workflows and plan effectively for the future. The platform provides unprecedented clarity, allowing for better management of equipment inventories, which ultimately enhances the overall effectiveness and efficiency of healthcare operations.

Gray Oncology Solutions

Pre Seed Round in 2021
Gray Oncology Solutions is focused on enhancing the oncology treatment process through innovative healthcare resource allocation software. The company aims to optimize the efficiency of cancer centers by developing a comprehensive operating system that streamlines workflows across various oncological interventions. This software automates patient scheduling and addresses the complexities of multi-disciplinary care, which allows healthcare providers to improve access to treatment, minimize patient wait times, and enhance both patient and staff satisfaction. By prioritizing personalized treatment journeys and statistically optimizing clinical outcomes, Gray Oncology Solutions ultimately strives to deliver superior patient care in the field of oncology.

Allevi

Venture Round in 2018
Allevi develops innovative tools for designing and engineering 3D tissues, focusing on bioprinting technology. The company offers desktop 3D bioprinters that allow users to create functional three-dimensional living tissues using various biomaterials and cell lines. Additionally, Allevi provides bioinks made from collagen and hyaluronic acid, which are available for purchase online. Their cloud-based platform, Bioprint Online, enables users to design complex structures, define materials, and monitor the printing process. Allevi's products serve a diverse clientele, including researchers in tissue engineering, regenerative medicine, and cell biology, as well as industrial and pharmaceutical companies for drug testing and development, and educators. Established in 2014 and based in Philadelphia, Pennsylvania, Allevi was formerly known as BioBots, Inc.

StageMark

Series B in 2007
StageMark develops and markets inflammatory diseases identification and monitoring solutions. The company's product, CB-CAPs, enables user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes. StageMark, Inc. was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.